Calcium antagonists, digoxin, calcaemia and anaemia in heart failure.

Basit Öğe Kaydı
dc.authoridBenli, Ali Ramazan/0000-0003-0039-1497
dc.contributor.authorYildiz, Sati Sena
dc.contributor.authorDikerdem, Didem
dc.contributor.authorBenli, Ali Ramazan
dc.contributor.authorKalem, Pinar
dc.contributor.authorCikrikcioglu, Mehmet Ali
dc.date.accessioned2024-09-29T16:11:37Z
dc.date.available2024-09-29T16:11:37Z
dc.date.issued2017
dc.departmentKarabük Üniversitesien_US
dc.description.abstractObjective: To reveal that Calcium Antagonist (CA) use is associated with lower haemoglobin (Hb) and digoxin use is associated with higher Hb in Heart Failure (HF). Method: 223 chronic HF patients in acute decompensation phase were included in the study. Patients with comorbidities leading to anemia and those receiving blood transfusion or antianaemic treatment were excluded. Patients were classified into two groups as anemic and non-anemic groups. Two groups were compared retrospectively with demographics, clinical findings, medication use, echocardiography findings, complete blood count and biochemistry. Different independent variables between two groups were subjected to Multivariate Binary Logistic Regression Analysis (MBLRA) under the dependent variable anemia. Multivariable linear Regression Analysis (RA) was also performed with the dependent variable of Hb. Results: MBLRA results showed that anemia was seen less frequently in digoxin users, whereas it was more frequent in the following conditions: CA use, chronic renal failure, lower AST, lower LDL cholesterol, lower triglyceride, lower Transferring Saturation Rate (TSR). RA results also showed that lower LDL cholesterol, lower eGFR, lower transferrin saturation rate, lower corrected calcium, female gender and CA use were associated with lower Hb; whereas, digoxin use was associated with higher Hb. Conclusions: Haemoglobin levels were found higher in digoxin users. CA use, lower corrected calcium and lower AST were associated with lower Hb in heart failure. These findings have not been reported so far.en_US
dc.identifier.endpage6756en_US
dc.identifier.issn0970-938X
dc.identifier.issn0976-1683
dc.identifier.issue15en_US
dc.identifier.startpage6749en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14619/8582
dc.identifier.volume28en_US
dc.identifier.wosWOS:000412521200040en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAllied Acaden_US
dc.relation.ispartofBiomedical Research-Indiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHeart failureen_US
dc.subjectAnemiaen_US
dc.subjectDigoxinen_US
dc.subjectCalcium antagonistsen_US
dc.subjectCalciumen_US
dc.titleCalcium antagonists, digoxin, calcaemia and anaemia in heart failure.en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu